
Pathophysiology-structural changes 2 ²¡ÀíÉúÀí-½á¹¹¸Ä±ä 2
Anatomically, four major alterations in anatomically [,?n?'t?mik?li] adv. ½á¹¹ÉÏ£»½âÆÊѧÉÏ
brain structure: ´óÄԽṹµÄËĸöÖ÷Òª¸Ä±ä£º
1. cortical atrophy Ƥ²ãÇøÎ®Ëõ
2. degeneration of cholinergic and other neurons µ¨¼îÄÜÉñ¾ÔªºÍÆäËûÉñ¾ÔªÍËÐÐÐÔ²¡±ä
3. neurofibrillary tangles Éñ¾ÏËά½á
4. accumulation of neuritic plaques.Éñ¾Ñ×ÐÔ°ß¿éÐî»ý
Neurofilibrillary tangles and neuritic plaques are considered the signature lesions
of
AD. Éñ¾½áºÍÉñ¾Ñ×ÐÔ°ß¿éÊÇADµÄ²¡ÀíÌØÕ÷¡£
But plaques and tangles may also be present in other diseases and even in normal
aging. µ«Êǰ߿éºÍ½á½ÚÒ²¿É¼ûÓÚÆäËü¼²²¡£¬ÉõÖÁÊÇÕý³£Ë¥ÀϵĴóÄÔ¡£
cortical ['k?:t?k?l]
adj. ƤÖʵģ»[ÉúÎï] Ƥ²ãµÄ£»ÍâÆ¤µÄ atrophy ['?tr?f?]
n. ήËõ£¬Î®ËõÖ¢£»·¢ÓýÍ£Ö¹ vi. ήËõ£»ÐéÍÑ
degeneration [d?,d?en?'re??(?)n] n. ÍË»¯£»[Ò½] ±äÐÔ£»¶éÂ䣻¶ñ»¯ cholinergic [,k??l?'n?:d??k] adj. À൨¼îµÄ
neurofibrillary: Éñ¾ÔªÏËά tangles
n. ²ø½á£»·þÊΣ»·ìÈÒ£¨tangleµÄ¸´Êý£©v. ʹ²ø½á£»¾íÈ루tangleµÄµÚÈýÈ˳Ƶ¥ÊýÐÎʽ£©
neuritic [,nju?'ritik, nju?'ritik]: adj. Éñ¾Ñ×µÄ
plaques: n. °ß¿é£»´ÉƬ£»½±Õ£»Êΰ壨plaqueµÄ¸´Êý£©
signature ['s ? gn ? t? ? ]: n. ÊðÃû£»Ç©Ãû£»
ÐźÅ
lesions: [ÉúÎï] ËðÉË
6
Neurofibrillary tangles Éñ¾ÏËά½á
NFTS are comprised of paired helical filaments that aggregate in dense bundles, appearing microscopically like tiny flames filling the neuronal cell be comprised of: ÓÉ?×é³É
helical ['hel?k(?)l; 'hi:-]: adj. ÂÝÐýÐ뵀 filaments ['fil?m?nts]
n. [Ö²] »¨Ë¿£»Ï¸Ë¿£¨filamentµÄ¸´Êý£©£»[µç×Ó] µÆË¿£»µç¼ÓÈÈË¿ aggregate ['?gr?g?t] body.Éñ¾ÏËά½áÓгɶԵÄÃܼ¯³ÉÊøµÄÂÝÐýË¿×é³É£¬Î¢¹Û¾ÍÏñÌî³äÉñ¾°ûÌåµÄС»ðÃç¡£
Paired helical filaments are formed from tau protein. Tau protein provides structure support to microtubules, the cell¡¯s transportation and skeletal support system.³É¶ÔµÄÂÝÐýË¿ÓÉtauµ°°××é³É£¬´Ëµ°°×Ϊ΢¹Ü¡¢ ϸ°ûÔËÊä¡¢¹Ç¼ÜÖ§³ÅϵͳÌṩ½á¹¹Ö§³Ö¡£ When tau filaments undergo abnormal phosphorylation at a specific site, they
can¡¯t bind effectively to microtubules. µ±tauË¿ÔÚÌØÒìλµãÁ×Ëữ£¬ËüÃǾͲ»ÄÜÓë΢¹ÜÓÐЧÀ¦°ó¡£
NFTs are found in other dementing illnesses besides AD, and may present a common method by which various factors culminate in cell death.Éñ¾ÏËά½á»¹³öÏÖÓÚADÒÔÍâµÄ³Õ´ôÐÔ¼²²¡ÖУ¬¿ÉÄÜÊÇϸ°ûËÀÍöʱ²»Í¬Òò×ÓÖÕ½áµÄÆÕ±é·½Ê½¡£
n. ºÏ¼Æ£»¼¯ºÏÌ壻×Ü¼Æ adj. ¾ÛºÏµÄ£»¼¯ºÏµÄ£»ºÏ¼ÆµÄ vi. ¼¯ºÏ£»¾Û¼¯£»ºÏ¼Æ vt. ¼¯ºÏ£»¾Û¼¯£»ºÏ¼Æ
dense [dens]: adj. ³íÃܵģ»Å¨ºñµÄ£»ÓÞ¶ÛµÄ
bundles: [½âÆÊ] Êø
appearing [?'pi?ri?]: v. ³öÏÖ£¬ÏԵã¨appearµÄingÐÎʽ£©
microscopically:adv. ÓÃÏÔ΢¾µ£»Í¨¹ýÏÔ΢¾µ
tiny ['ta?n?]: adj. ΢СµÄ£»ºÜÉÙµÄ
flames [fleimz]: n. [»¯¹¤] »ðÑæ£»»ðÃ磨flameµÄ¸´ÊýÐÎʽ£© skeletal ['skel?t(?)l; sk?'li:t(?)l] adj. ¹Ç÷ÀµÄ£¬Ïñ¹Ç÷ÀµÄ£»º¡¹ÇµÄ£»¹ÇÊÝÈç²ñµÄ
phosphorylation [f?,sf?ri'lei??n]: n. [Óл¯] Á×Ëữ×÷ÓÃ
dement [d?'ment]: n. ³Õ´ôÖ¢ culminate in: ´ïµ½¶¥µã£»ÒÔ?¸æÖÕ culminate ['k?lm?ne?t]: vt. ʹ½áÊø£»Ê¹´ïµ½¸ß³± vi. µ½¾ø¶¥£»´ïµ½¸ß³±¡£
7
Neuritic plaques (amyloid or senile plaques)
Éñ¾Ñ×Ð԰߿飨µí·ÛÐÔµ°°×»òÀÏÄê°ß£© Extracellular lesions found in the brain and cerebral vasculature. ÔÚÄԺʹóÄÔÂö¹Üϵͳ·¢ÏÖϸ°ûÍâË𺦡£
Plaques are comprised of beta-amyloid protein and an entwined of broken
neurites. °ß¿éÓɦÂ-µí·ÛÐÔµ°°×ºÍÒ»¸öË𻵵ÄÑ×ÐÔÉñ¾Í»Æð²øÈÆ×é³É¡£
Astrocytes and microglia are also found in plaques. °ß¿éÖÐÒ²·¢ÏÖÐÇÐνºÖÊϸ°ûºÍС½ºÖÊϸ°û¡£
Strangely enough, the number of neuritic plaques does not necessarily determine
disease
severity. ÓÐȤµØ£¬¼²²¡ÑÏÖØ³Ì¶È²»È¡¾öÓÚ°ß¿éµÄÊýÁ¿¡£
Clinical development of AD may correlate inversely with the number of normal neurons and synapses remaining despite plaque presence. ¾¡¹ÜÓа߿éµÄ³öÏÖ£¬ADµÄÁÙ´²·¢Õ¹¿ÉÄÜÓëÕý³£Éñ¾ÔªºÍÍ»´¥µØ²ÐÁôÊýÁ¿³Ê·´±È¡£
amyloid ['?m?l??d]: n. µí·ÛÌ壻µí·ÛÖÊʳÎï; adj. º¬µí·ÛµÄ£»µí·ÛÖ浀 senile ['si:na?l]: adj. ¸ßÁäµÄ£»ÀÏË¥µÄ extracellular [ekstr?'selj?l?]
[ÉúÎï] ϸ°ûÍâµÄ£¨¸±extracellularly£© lesion ['li:?(?)n] n. Ë𺦠cerebral ['ser?br(?)l; s?'ri:br(?)l] adj. ´óÄԵģ¬ÄÔµÄ
vasculature ['v?skjul?t??(r)]: n. Âö¹Üϵͳ
entwine [?n'twa?n; en-]: vt. ²ø×¡£»ÅÌ
ÈÆ£»Ê¹²øÈÆ : vi. ²ø×¡£»ÅÌÈÆ neurite ['nju?rait]: n. [×éÖ¯] Éñ¾Í»
microglia [mai'kr?¨Àlai?] n. [×éÖ¯] СÉñ¾½ºÖÊϸ°û
strangely enough
˵À´Ò²Ææ¹Ö£¨ÓÃ×÷²åÈëÓ strangely ['streind?li]
adv. Ææ¹ÖµØ£»ÆæÃîµØ£»²»¿É˼Ò鵨
severity [s?'ver?t?]:n. ÑÏÖØ£»Ñϸñ
inversely ['?nv?:sl?] adv. Ïà·´µØ£»µ¹×ªµØ synapses [si'n?psi:z]
n. [½âÆÊ] Í»´¥£¨synapseµÄ¸´Êý£©
8
beta-Amyloid protein¦Â-µí·ÛÐÔµ°°× Forming the center of the neuritic plaque are aggregates of a 39-43 amino acid protein segment called AP-beta, which is cleaved from the amyloid precursor (APP),
a
transmembrane
cleave [kli:v]
vt. ¿³¿ª£»Ê¹·Ö¿ª£»´òͨ
vi. ÁÑ¿ª£»Åû¾£Õ¶¼¬µØÇ°½ø£»Õ³×¡£»¼á³Ö
precursor [pr?'k?:s?]: n. ÏÈÇý£¬Ç°µ¼
protein.
Éñ¾Ñ×ÐÔ°ß¿éÖÐÐÄÓÉÒ»¸ö½Ð×öAP-betaµÄ39-43 ëݱ»ùËáµ°°×¾ÛºÏÎï×é³É£¬´ËΪµí·ÛÐÔµ°°×ǰÌ壨һÖÖ¿çĤµ°°×£©ÍÑÂä¶ø³É¡£
Proteases cleave APP in several different ways. It has been demonstrated that the 42 amino acid form of AP-beta is more amyloidogenic than other forms of
AP-beta. µ°°×ø¾²»Í¬·½Ê½·Ö½âAPP £¬ÒѲûÃ÷42ëĵÄAP-¦Â°±»ùËá±ÈÆäËüÐ͸üÒ×Éú³ÉAP-¦Â ¡£
Deposits of AP-beta are ¡°assumed¡± to be the initiating cause of AD. AP-¦ÂµÄ³Á×ű»¼ÙÉèΪADµÄ·¢ÉúÔÒò¡£ Animal experiments in vivo and in vitro ¨Csuggesting AP-beta deposition occurs early
in
the
disease
process. ÌåÄÚºÍÌåÍâµÄ¶¯ÎïÊÔÑé±íÃ÷AP- ¦Â³Á×ÅÎï³öÏÖÔÚ¼²²¡¹ý³ÌµÄÔçÆÚ¡£ Question: APP is not limited to the brain.
Why AP-beta selectively deposits in the brain
as opposed to other anatomic sites. APP²»½öÏÞÓÚ´óÄÔ£¬µ«ÎªÊ²Ã´AP-¦ÂÑ¡ÔñÐÔ³Á»ýÓÚ´óÄÔ¶ø·ÇËû´¦ÄØ£¿
proteases£ºn. [Éú»¯] µ°°×ø£¨proteaseµÄ¸´Êý£©
Amyloidogenic: µí·ÛÑùµ°°× deposit [d?'p?z?t]
n. ´æ¿î£»±£Ö¤½ð£»³ÁµíÎï vt. ʹ³Á»ý£»´æ·Å vi. ³Áµí
assumed [?'sju:md] adj. ¼Ù¶¨µÄ£»¼Ù×°µÄ initiating [i'ni?ieiti?]
v. ¿ªÊ¼£¨initiateµÄingÐÎʽ£© deposition [,dep?'z??(?)n; di?-] n. ³Á»ýÎ¿ó´²£»¸ïÖ°£»[ÂÉ]£¨ÔÚ·¨Í¥Éϵģ©ÐûÊÄ×÷Ö¤£¬Ö¤´Ê
as opposed to: Óë?½ØÈ»Ïà·´£»¶ÔÕÕ
oppose [?'p??z] vt. ·´¶Ô£»¶Ô¿¹£¬¿¹Õù vi. ·´¶Ô
anatomic [,?n?'t?mik]
adj. ×éÖ¯µÄ£»½âÆÊѧÉϵģ»½á¹¹ÉϵÄ
9
Genetic causes ÒÅ´«ÔÒò
It used to be thought that early-onset cases of AD were genetic, whereas the more common later onset cases were genetic [d??'net?k]
adj. ÒÅ´«µÄ£»»ùÒòµÄ£»ÆðÔ´µÄ whereas [we?r'?z] conj. È»¶ø£»¼øÓÚ£»·´Ö® sporadic. ÒÔǰͨ³£ÈÏΪADµÄÔçÆÚ·¢²¡ÔÒòÊÇÒÅ´«£¬È»¶øÍíÆÚ²¡ÀýÊÇÉ¢·¢µÄ¡£
Recent genetic research has obliterated the distinctions between familial and sporadic with the discovery of the apolipoprotein
E4
allele
on
chromosome 19, which influences
susceptibility to late-onset cases¡£ Ëæ×Å19ºÅȾɫÌåÉϵÄE4µÈλ»ùÒò--É¢·¢ÐÔ£¬ÍíÆÚ·¢²¡²¡Àý¡£
Almost all early-onset cases of AD can be
atributed
to alterations on
chromosome 1,
14,
and
21. ¼¸ºõËùÓеÄADÔçÆÚ²¡Àý¶¼¿É¹éÒòÓÚ1¡¢14¡¢21ºÅȾɫÌåµÄ¸Ä±ä¡£
sporadic [sp?'r?d?k]
adj. ÁãÐǵģ»·ÖÉ¢µÄ£»²»¶¨Ê±·¢ÉúµÄ
obliterate [?'bl?t?re?t] vt. ÏûÃð£»Í¿È¥£»³åË¢£»Íüµô familial [f?'m?lj?l]
adj. ¼Ò×åµÄ£»¼ÒÍ¥µÄ£»ÒÅ´«µÄ apolipoprotein ['?p?,lip?'pr?uti:n] n. [Éú»¯] ÔØÖ¬µ°°×£»
allele ['?li:l] n. [ÒÅ] µÈλ»ùÒò
chromosome ['kr??m?s??m]
n. [ÒÅ][ϸ°û][ȾÁÏ] ȾɫÌ壨ÐÎÈÝ´Êchromosomal£¬¸±´Êchromosomally£© susceptibility [s?,sept?'b?l?t?] n. Ãô¸ÐÐÔ£»¸ÐÇ飻´Å»¯ÏµÊý
10
°Ù¶ÈËÑË÷¡°77cn¡±»ò¡°Ãâ·Ñ·¶ÎÄÍø¡±¼´¿ÉÕÒµ½±¾Õ¾Ãâ·ÑÔĶÁÈ«²¿·¶ÎÄ¡£Êղر¾Õ¾·½±ãÏ´ÎÔĶÁ£¬Ãâ·Ñ·¶ÎÄÍø£¬Ìṩ¾µäС˵×ÛºÏÎÄ¿âҩѧרҵӢÓï-AD-½²¸å(2)ÔÚÏßÈ«ÎÄÔĶÁ¡£
Ïà¹ØÍÆ¼ö£º
